Tag Archives: human therapeutic antibodies

Almirall partners with Ablexis and AlivaMab Discovery Services to accelerate its development efforts for innovative treatment options for patients suffering from severe skin diseases

Posted on 31, January 2022 by EuropaWire PR Editors

Through this license agreement with Ablexis, Almirall is granted rights to use the AlivaMab® Mouse technology for research, development, and commercialisation of antibodies AlivaMab Mouse offers state-of-the-art transgenic mouse platforms delivering highdiversity human therapeutic antibodies Almirall will partner with AlivaMab … Read the full press release →

Posted in Healthcare, News, Pharma & Biotech, Science, Spain, Technology

Tagged Ablexis, AlivaMab Discovery Services, AlivaMab Mouse, Almirall, antibody drug, antibody therapeutics, biopharmaceutical, dermatological conditions, Dr. Thomas Huber, human therapeutic antibodies, Justin Mika, Larry Green, licensing agreement, severe skin diseases, skin health